Introduction {#s1}
============

The most recent Surgeon General's Report (SGR), "E-cigarette use among youth and young adults", was released in December of 2016.^[@CIT0001]^ The 2016 SGR follows the legacy of SGRs that began in 1964.^[@CIT0002]^ The 1964 SGR is not only respected for its positive impact on public health, but also its methodological rigor. As noted in the 2014 SGR, the 1964 SGR included a "transparent methodology and depth of analysis, including a systematic gathering and review of the data and a synthesis of the findings for causality based on prior criteria".^[@CIT0003](p21)^ Upon a first inspection, the 2016 SGR appears to embody the same objective review of evidence with the involvement of more than 100 experts and close to 1000 references. A more careful read, however, reveals important areas where the report falls short.

Objectivity {#s2}
===========

One of the more surprising shortcomings of the 2016 SGR is located early in the document when the reader is informed that recent studies were included if they conformed to conclusions that had already been reached, or as stated: "...selected studies from 2016 have been added during the review process that provide further support for the conclusions in this report." (see Chapter 1: "Scientific Basis of the Report"^[@CIT0001](p5)^). While efforts to include recently published studies are commended, especially when evaluating rapidly changing technology such as e-cigarettes, the selection of evidence to align with preset conclusions represents a type of bias known as "confirmation bias." Confirmation bias is defined as "The seeking or interpreting of evidence in ways that are partial to existing beliefs, expectations, or a hypothesis in hand."^[@CIT0004](p175)^ The degree to which confirmation bias impacted the conclusions of the 2016 SGR requires a more in-depth analysis than is possible in this brief commentary, but the potential for such bias should not be overlooked given the negative impact it can have on science, medicine, and policy.^[@CIT0004]^

Evidence {#s3}
========

There is additional evidence that the 2016 SGR falls short of providing a comprehensive overview of the literature. For example, two recent publications that found evidence that age-of-purchase restrictions on e-cigarettes can contribute to increased use of combustible cigarettes by adolescents were not included in the report.^[@CIT0005],[@CIT0006]^ In a separate section of the report titled "Attention and Cognition"^[@CIT0001](pp106--107)^, only one citation addressed the effects of nicotine on human cognition out of 12 studies cited. The 11 remaining citations examined the effects of nicotine in rodents (7 studies) or in humans exposed to smoked tobacco only (4 studies). This is surprising given that a considerable body of research has examined nicotine's effects on human cognition as reviewed in a 2010 meta-analysis of nicotine's effects on performance.^[@CIT0007]^ That meta-analysis included 15 studies that assessed the acute effects of nicotine alone, not smoked tobacco, on cognitive performance of young people with a mean age between 19 and 24 years across studies (see Tables 2--10 of ref. ^[@CIT0007]^ for mean age by study). Unfortunately, neither the meta-analysis nor any of these 15 studies were addressed in the 2016 SGR.

Similarly, the 2016 SGR did not account for the only human study to-date that has followed infants exposed to nicotine in utero over an extended period of time after delivery.^[@CIT0008]^ That study, a randomized controlled trial based in England and known as the SNAP trial (Smoking and Nicotine in Pregnancy), examined the effects of nicotine replacement therapy (NRT) on smoking during pregnancy. The study found that infants born to women that had used NRT during pregnancy were more likely to have unimpaired development at a 2-year follow-up compared to infants who had been in a placebo group. SNAP authors noted that this difference could be due to reduced smoking in the NRT group early in pregnancy. A potential implication of this finding is that prenatal exposure to combusted tobacco is more harmful than other forms of noncombusted nicotine exposure such as NRT. Such findings are essential for understanding the unique challenges and opportunities that are associated with addressing smoking and nicotine exposure during pregnancy, a topic that was reviewed at length in a recent Themed Issue of Nicotine and Tobacco Research.^[@CIT0009]^

Conclusions and Recommendations {#s4}
===============================

The above concerns highlight serious methodological oversights that greatly restrict the ability of the 2016 SGR to offer an objective review of the best available evidence related to the health effects of nicotine, tobacco, and e-cigarettes. Incomplete or biased messaging on the effects of these and other nicotine products must be avoided at all costs in order to support the public in making personal choices that are informed by the best available evidence.^[@CIT0010]^ An emphasis on objectivity and evidence is essential for correcting oversights in the 2016 SGR and reinstating the SGR's legacy as a health communication tool that serves the public.
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